Hypoglycaemic effect of quinolizidine alkaloids — lupanine and 2-thionosparteine on non-diabetic and streptozotocin-induced diabetic rats

2007 ◽  
Vol 565 (1-3) ◽  
pp. 240-244 ◽  
Author(s):  
Teresa Bobkiewicz-Kozłowska ◽  
Marzena Dworacka ◽  
Sebastian Kuczyński ◽  
Małgorzata Abramczyk ◽  
Renata Kolanoś ◽  
...  
2006 ◽  
Vol 38 (3) ◽  
pp. 194 ◽  
Author(s):  
PD Djomeni Dzeufiet ◽  
L Tedong ◽  
EA Asongalem ◽  
T Dimo ◽  
SD Sokeng ◽  
...  

2004 ◽  
Vol 56 (6) ◽  
pp. 795-799 ◽  
Author(s):  
A. Lemhadri ◽  
N.-A. Zeggwagh ◽  
M. Maghrani ◽  
H. Jouad ◽  
J. B. Michel ◽  
...  

Author(s):  
Anthoneth Ndidi Ezejiofor ◽  
Zelinjo Nkeiruka Igweze ◽  
Nnaemeka Arinze Udowelle ◽  
Orish Ebere Orisakwe

AbstractBackground:In continuation of our study of the biological activity of the aqueous extract ofMethods:Thirty male albino Wistar rats (150−200 g) were weight-matched into six groups of five rats each. Groups 1 and 2 were the normal (non-induced) and toxic (alloxan-induced) controls, respectively. Groups 3−6 were induced and treated with 1, 2 and 3 g/kg of the aqueous extract ofResults:There was a significant reduction in alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total bilirubin triglyceride, creatinine, urea and electrolyte when compared with toxic control group. The liver marker enzymes were restored in all the treated groups. The aqueous stem extract possessed hypoglycaemic effect and reversed the histopathological damage in alloxan-induced diabetic rats.Conclusions:This study suggests that aqueous stem extract of


2007 ◽  
Vol 17 (2) ◽  
pp. 166-169 ◽  
Author(s):  
Fatima Torrico ◽  
Mariana Cepeda ◽  
Geraldine Guerrero ◽  
Fidel Melendez ◽  
Zuleima Blanco ◽  
...  

2018 ◽  
Vol 1 (1) ◽  
pp. 11-18
Author(s):  
H. M. Olaitan

Diabetes is a metabolic disease that has caused severe health complications and premature deaths in both developed and developing countries. It is characterized by hyperglycaemia. This study was designed to investigate the hypoglycaemic effect of methanol extract of Aframomum melegueta seed in Alloxan-induced diabetic rats. Adult albino rats of either sex weighing between 90 – 150 g were used. Diabetes was induced by administration of alloxan (100 mg/kg i.p). The rats were seperated into 5 groups of five rats each. Group I served as the negative control and was given normal saline (10 ml/kg p.o). Groups II – IV were given A. melegueta extract at varying doses of 100, 200 and 400 mg/kg p.o respectively. Group V was treated with Glibenclamide at a dose of 2 mg/kg p.o to serve as the positive control. The various treatments were administered for a period of 14 days. The Fasting Blood Glucose (FBG) levels of the rats were determined before and weekly after commencement of treatment with the aid of a glucometer using blood collected from the tail vein. Result revealed that there was a significant (p<0.05) reduction of the Fasting Blood Glucose level after 14 days of treatment in the diabetic groups as compared to the FBG before the treatment. However, there was no significant difference (p>0.05) in the mean Fasting Blood Glucose levels between groups treated with varying doses of A. melegueta seed extract. Also, there was no significant difference (p>0.05) between groups treated with A. melegueta extract and the group treated with Glibenclamide. The investigation showed that A. melegueta seed extract had hypoglycaemic effect in Alloxan – induced diabetic rats which was comparable with that of Glibenclamide, a conventionally used hypoglycaemic drug. However, the hypoglycaemic effect of the extract was not dose dependent. This therefore suggests that Aframomum melegueta seed has a useful potential for the treatment of diabetes mellitus due to its hypoglycaemic effect.


Sign in / Sign up

Export Citation Format

Share Document